Publication

Peyton CC, Chipollini J, Azizi M, Kamat AM, Gilbert SM, Spiess PE. 2018 Dec. Updates on the use of intravesical therapies for non-muscle invasive bladder cancer: how, when and what. World J Urol. doi:10.1007/s00345-018-2591-1.

Boese CJ, Nye J, Buster DW, McLamarrah TA, Byrnes AE, Slep KC, Rusan NM, Rogers GC. 2018. Asterless is a Polo-like kinase 4 substrate that both activates and inhibits kinase activity depending on its phosphorylation state. Mol Biol Cell. 29:2874–2886. doi:10.1091/mbc.E18-07-0445.

Song B, Sunny S, Uthoff RD, Patrick S, Suresh A, Kolur T, Keerthi G, Anbarani A, Wilder-Smith P, Kuriakose MA, et al. 2018. Automatic classification of dual-modalilty, smartphone-based oral dysplasia and malignancy images using deep learning. Biomed Opt Express. 9:5318–5329. doi:10.1364/BOE.9.005318.

Oh M, McBride A, Yun S, Bhattacharjee S, Slack M, Martin JR, Jeter J, Abraham I. 2018. BRCA1 and BRCA2 Gene Mutations and Colorectal Cancer Risk: Systematic Review and Meta-analysis. J Natl Cancer Inst. 110:1178–1189. doi:10.1093/jnci/djy148.

Peyton CC, Tang D, Reich RR, Azizi M, Chipollini J, Pow-Sang JM, Manley B, Spiess PE, Poch MA, Sexton WJ, et al. 2018. Downstaging and Survival Outcomes Associated With Neoadjuvant Chemotherapy Regimens Among Patients Treated With Cystectomy for Muscle-Invasive Bladder Cancer. JAMA Oncol. 4:1535–1542. doi:10.1001/jamaoncol.2018.3542.

Wu H, Chen X, Yang X, Tao Y, Xia Y, Deng X, Zheng C, Robbins J, Schultz C, Li XA. 2018. Early Prediction of Acute Xerostomia During Radiation Therapy for Head and Neck Cancer Based on Texture Analysis of Daily CT. Int J Radiat Oncol Biol Phys. 102:1308–1318. doi:10.1016/j.ijrobp.2018.04.059.

Bahig H, Yuan Y, Mohamed ASR, Brock KK, Ng SP, Wang J, Ding Y, Hutcheson K, McCulloch M, Balter PA, et al. 2018. Magnetic Resonance-based Response Assessment and Dose Adaptation in Human Papilloma Virus Positive Tumors of the Oropharynx treated with Radiotherapy (MR-ADAPTOR): An R-IDEAL stage 2a-2b/Bayesian phase II trial. Clin Transl Radiat Oncol. 13:19–23. doi:10.1016/j.ctro.2018.08.003.

Schembre SM, Liao Y, O’Connor SG, Hingle MD, Shen S-E, Hamoy KG, Huh J, Dunton GF, Weiss R, Thomson CA, et al. 2018. Mobile Ecological Momentary Diet Assessment Methods for Behavioral Research: Systematic Review. JMIR Mhealth Uhealth. 6:e11170. doi:10.2196/11170.

Chen W, Feng Y, Molnár I, Chen F. 2018 Nov. Nature and nurture: confluence of pathway determinism with metabolic and chemical serendipity diversifies Monascus azaphilone pigments. Nat Prod Rep. doi:10.1039/c8np00060c.

Chen Y, Lou Y, Wang K, Kupinski MA, Anastasio MA. 2018 Nov. Reconstruction-Aware Imaging System Ranking by use of a Sparsity-Driven Numerical Observer Enabled by Variational Bayesian Inference. IEEE Trans Med Imaging. doi:10.1109/TMI.2018.2880870.

Kaushansky A, Hedstrom L, Goldman A, Singh J, Yang PL, Rathod PK, Cynamon M, Wodarz D, Mahadevan D, Tomaras A, et al. 2018. A call to arms: Unifying the fight against resistance. Sci Signal. 11. doi:10.1126/scisignal.aav0442.

Liao Y, Schembre S. 2018. Acceptability of Continuous Glucose Monitoring in Free-Living Healthy Individuals: Implications for the Use of Wearable Biosensors in Diet and Physical Activity Research. JMIR Mhealth Uhealth. 6:e11181. doi:10.2196/11181.

Bea JW, Funk J, Hetherington-Rauth M, Wertheim BC, Mosquiera L, Thuraisingam R, Lee V, Blew R, Lohman T, Roe DJ, et al. 2018. Anthropometry Versus Imaging for Prediction of Inflammation Among Hispanic Girls. Obesity (Silver Spring). 26:1594–1602. doi:10.1002/oby.22265.

Scott AJ, Arcaroli JJ, Bagby SM, Yahn R, Huber KM, Serkova NJ, Nguyen A, Kim J, Thorburn A, Vogel J, et al. 2018. Cabozantinib Exhibits Potent Antitumor Activity in Colorectal Cancer Patient-Derived Tumor Xenograft Models via Autophagy and Signaling Mechanisms. Mol Cancer Ther. 17:2112–2122. doi:10.1158/1535-7163.MCT-17-0131.

Stanton AL, Wiley JF, Krull JL, Crespi CM, Weihs KL. 2018. Cancer-related coping processes as predictors of depressive symptoms, trajectories, and episodes. J Consult Clin Psychol. 86:820–830. doi:10.1037/ccp0000328.

Gharaibeh M, McBride A, Alberts DS, Slack M, Erstad B, Alsaid N, Bootman JL, Abraham I. 2018. Economic Evaluation for USA of Systemic Chemotherapies as First-Line Treatment of Metastatic Pancreatic Cancer. Pharmacoeconomics. 36:1273–1284. doi:10.1007/s40273-018-0678-6.

McGregor H, Sun Z, McCoy D, Kumar V, Conrad M, Wilson M, Cooke D. 2018. Endovascular Biopsy and Endothelial Cell Gene Expression Analysis of Dialysis Arteriovenous Fistulas: A Feasibility Study. J Vasc Interv Radiol. 29:1403–1409.e2. doi:10.1016/j.jvir.2018.04.034.

Tajeu GS, Halanych J, Juarez L, Stone J, Stepanikova I, Green A, Cherrington AL. 2018. Exploring the Association of Healthcare Worker Race and Occupation with Implicit and Explicit Racial Bias. J Natl Med Assoc. 110:464–472. doi:10.1016/j.jnma.2017.12.001.

Rak MA, Buehler J, Zeltzer S, Reitsma J, Molina B, Terhune S, Goodrum F. 2018. Human Cytomegalovirus UL135 Interacts with Host Adaptor Proteins To Regulate Epidermal Growth Factor Receptor and Reactivation from Latency. J Virol. 92. doi:10.1128/JVI.00919-18.

Bachman AS, Cohen EL, Collins T, Hatcher J, Crosby R, Vanderpool RC. 2018. Identifying Communication Barriers to Colorectal Cancer Screening Adherence among Appalachian Kentuckians. Health Commun. 33:1284–1292. doi:10.1080/10410236.2017.1351274.

Mantyh PW. 2018 Oct. Mechanisms that drive bone pain across the lifespan. Br J Clin Pharmacol. doi:10.1111/bcp.13801.

Bauman JE, Duvvuri U, Thomas S, Gooding WE, Clump DA, Karlovits B, Wehbe A, Miller FR, Kim S, Sen M, et al. 2018. Phase 1 study of EGFR-antisense DNA, cetuximab, and radiotherapy in head and neck cancer with preclinical correlatives. Cancer. 124:3881–3889. doi:10.1002/cncr.31651.

Adegboyega A, Aroh A, Voigts K, Jennifer H. 2018 Oct. Regular Mammography Screening Among African American (AA) Women: Qualitative Application of the PEN-3 Framework. J Transcult Nurs.:1043659618803146. doi:10.1177/1043659618803146.

Chatterjee S, Chakraborty P, Daenthanasanmak A, Iamsawat S, Andrejeva G, Luevano LA, Wolf M, Baliga U, Krieg C, Beeson CC, et al. 2018 Oct. Targeting PIM Kinase with PD1 inhibition Improves Immunotherapeutic Antitumor T-cell Response. Clin Cancer Res. doi:10.1158/1078-0432.CCR-18-0706.

Cartwright TH, Parisi M, Espirito JL, Wilson TW, Pelletier C, Patel M, Babiker HM. 2018. Clinical Outcomes with First-Line Chemotherapy in a Large Retrospective Study of Patients with Metastatic Pancreatic Cancer Treated in a US Community Oncology Setting. Drugs Real World Outcomes. 5:149–159. doi:10.1007/s40801-018-0137-x.